A study to evaluate combination therapy of memantine hydrochloride with donepezil hydrochloride compared with dose escalation of donepezil hydrochloride in the patient with Alzheimer's disease who have treated with donepezil hydrochloride
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Donepezil (Primary) ; Memantine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 26 Apr 2017 Status changed from active, no longer recruiting to discontinued.
- 22 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Nov 2016 Status changed from not yet recruiting to recruiting.